Guru Murthy, Guru Subramanian <br/><br/>
Myeloid malignancies after treatment for solid tumours.  [electronic resource] 

 -  Best practice & research. Clinical haematology  03 2019 
 - 40-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-1924 
<br/><br/><label>Standard No.: </label>10.1016/j.beha.2019.02.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Chemotherapy, Adjuvant--adverse effects<br/>Female<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Hematologic Neoplasms--chemically induced<br/>Humans<br/>Male<br/>Myeloproliferative Disorders--chemically induced<br/>Neoplasms, Second Primary--metabolism<br/>Platinum--adverse effects<br/>Risk Factors<br/>Topoisomerase II Inhibitors--adverse effects